✦ LIBER ✦

237 A phase I study of irinotecan (CPT-11) and capecitabina (XL) as second line treatment in advanced colorectal cancer

✍ Scribed by P. Garcia-Alfonso; A. Munoz; M. Méndez; S. Garcia-Adrian; P. Lopez-Criado; R. Alvarez; I. Siso; G. Pérez-Manga

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of weekly irinotecan (CPT

✍ J. Cassinello; P. López-Alvarez; A. Martínez-Guisado; M. Valladares; G. Huidobro 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 106 KB

A phase II study of biweekly irinotecan

✍ Salvador, J.; Bernabe, R.; Bolaños, M.; Borrega, P.; Valladares, M.; Cobo, M.; R 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 371 KB

Phase I trial of weekly irinotecan combi

✍ V Alonso; P Escudero; M Zorrilla; M.D Isla; A Herrero; J.I Mayordomo; J Martinez 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 105 KB

A phase I study of combination therapy w

✍ Manabu Shiozawa; Nobuhiro Sugano; Kazuhito Tsuchida; Soichiro Morinaga; Makoto A 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 296 KB

A phase II study of weekly irinotecan (C

✍ Cruz, J.; Mendez, M.; Alfonso, P.; Gonzalez, E.; Pujol, E.; Castañon, C.; Cerezu 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 206 KB

Activity and safety of capecitabine and

✍ Bajetta, E.; Cortinovis, D.; Cassata, A.; Siena, S.; Cartei, G.; Pinotti, G.; Ca 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 189 KB